Optical Goods Retailers (U.S.) — NAICS 456130

A primer on the businesses that sell eyeglasses, contact lenses, and sunglasses to American consumers — for both public-market and private investors.

1. Overview

Optical goods retailers are where Americans actually buy vision correction: prescription eyeglasses, contact lenses, and prescription and non-prescription sunglasses. The category spans the LensCrafters at the mall, the America's Best in a strip center, the independent optician on Main Street, and, increasingly, online sellers like Warby Parker and Zenni. Under the U.S. Census Bureau's narrow store definition — North American Industry Classification System (NAICS) code 456130, the government's standard scheme for grouping businesses — the industry is about 11,719 store locations run by roughly 3,942 firms.[1][2]

It is a hybrid of health care and consumer retail. Customers need correction, but retailers still compete on price, fashion, convenience, insurance acceptance, speed, and trust. That combination gives the business staple-like, recurring characteristics most discretionary retail lacks: people refill contact lenses on a schedule, replace glasses for prescription and style reasons, and return for annual exams. At the same time it is being reshaped by direct-to-consumer (DTC — selling straight to shoppers online and through owned stores rather than through third parties) upstarts, private-equity roll-ups, and a brand-new smart-glasses category.

Access differs sharply by investor type. Public-market investors reach the sector through a handful of listed names — the global giant EssilorLuxottica, the value chain National Vision, and the DTC brand Warby Parker are the cleanest. Private investors reach it by buying or franchising an optical practice, financing a lab or retail platform, or co-investing alongside the private-equity firms and member-owned insurers that control most of the large chains. Both routes are covered below. One caveat throughout: optical retail is not the same as the wider eyewear or eye-care market, and the two are easy to confuse.

2. What it is and how it's structured

Scope. NAICS 456130 covers establishments that (1) retail and fit prescription eyeglasses and contact lenses, (2) retail eyeglasses while grinding lenses to order on site, or (3) retail non-prescription eyeglasses and sunglasses.[3] The core basket is frames and prescription lenses, contact lenses, prescription and non-prescription sunglasses, lens upgrades, repairs, accessories, and the eye exams and fittings often delivered alongside the sale. It sits inside the retail-trade subsector for health and personal-care retailers.

What it excludes (this shapes every official number). The code is a store category and deliberately leaves out big chunks of eyewear economics:

• Doctors' offices. Independent optometry and ophthalmology practices — even when the doctor sells glasses and contacts — are health care, classified under NAICS 621 (Ambulatory Health Care Services), specifically Offices of Optometrists (621320).[3] The eye-exam revenue that drives store traffic largely lives there, not in 456130.
• Manufacturing. Grinding ophthalmic lenses without retailing them is NAICS 339115 (Ophthalmic Goods Manufacturing).[3]
• Big-box and mass-merchant optical. Optical counters inside general-merchandise giants (Walmart Vision Centers, Costco Optical, Sam's Club) are folded into their parent stores under general merchandise, not counted here. Two of the largest eyewear sellers in America therefore barely register in 456130.

A measurement wrinkle: older NAICS systems put mail-order and electronic eyewear in a separate non-store category, and the 2022 revisions reshuffled several non-store lines into merchandise-based codes.[4] Company filings and business-unit disclosures are more reliable than assuming 456130 is purely brick-and-mortar.

Ownership mix — a barbell. On one end, thousands of small independent opticians and single-store optometry-plus-optical shops; on the other, a few enormous chains, insurer-affiliated retailers, and vertically integrated manufacturer-retailers. Federal data shows the split clearly: within 456130 the four largest firms take an estimated 61.5% of receipts, the top eight 71.7%, the top 20 about 77%.[2] The average firm runs roughly three locations (11,719 stores across 3,942 firms), but that average hides the gap between mom-and-pops and national brands.[1][2] In many states the retail store and the eye-care professional are separate legal entities, connected through a management-services organization (MSO), because "corporate practice" laws restrict who may own a clinical practice.

3. How big it is

Federal ground truth (the narrow store category, NAICS 456130):

The market-concentration index for this industry (the Herfindahl-Hirschman Index, a standard measure that squares and sums every firm's market share) is suppressed in the federal data, so we do not report a value. The Small Business Administration (SBA) small-business ceiling of $29.5 million in average annual receipts[5] is an eligibility threshold for federal programs, not an industry forecast — but it confirms the government treats the overwhelming majority of these retailers as small businesses, consistent with the thousands of independents in the count.

The undercount caveat (read before quoting any number). The $15.68 billion is the receipts of firms classified specifically as optical goods stores.[2] It understates the industry's economic footprint two ways. First, County Business Patterns covers only employer establishments — it excludes the self-employed, businesses without employees or an employer identification number, and has known undercoverage of very small multiunit firms.[6] Second, the classification omits the excluded pieces above: exam and product revenue at optometrists' offices, online pure-plays, and Walmart/Costco optical departments. Treat the federal $15.68 billion as the employer-storefront floor, not the whole eyewear economy.

Private and trade estimates of the broader market run far higher and vary by definition. The Vision Council, the industry's main trade group, put the broader U.S. optical industry at about $69.5 billion for 2025, a figure that includes eye exams and multiple product categories and is therefore not comparable with 456130 receipts.[7] Other market-research estimates for "eyewear" or "optical retail" land anywhere from the high-teens billions to the mid-$60-billions depending on what they count.[7][8]

4. The investable universe

Few clean public plays exist; most large chains are private or owned by insurers and private-equity firms. Tickers, share prices, and market values are reserved for this section and Section 10.

Public companies

Walmart (WMT) and Costco (COST) rank near the top of U.S. optical-sales tables, but optical is embedded in their health/ancillary operations with no standalone disclosure, so they are not eyewear investments in any meaningful sense.[15][16] Upstream, the contact-lens and lens makers — Alcon (ALC), Cooper Companies (COO), Bausch + Lomb (BLCO), and Johnson & Johnson's vision unit — are suppliers to this industry, not retailers. No listed company cleanly represents the whole NAICS category: focused retailers disclose the most operating detail, diversified giants offer breadth but little optical visibility.

Major private and other owners

• VSP Vision — a member-owned not-for-profit that is the largest U.S. vision insurer and also owns the Visionworks store chain and lens/frame businesses; it acquired the value chain Eyemart Express (announced October 2024, since completed) from private-equity firms FFL Partners and Leonard Green.[17]
• MyEyeDr / Capital Vision Services — a Goldman Sachs–backed optometry-led platform; its acquisitions site reports partnering with more than 900 private practices.[18]
• EyeCare Partners — a private, clinically integrated eye-care platform backed by Partners Group, spanning medical optometry, ophthalmology, and vision correction.[19]
• Now Optics / Stanton Optical — founder-owned, 300-plus locations, a technology-enabled retail model the company says it bootstrapped without outside institutional capital.[20]
• U.S. Vision / Refac Optical Group — a licensed-department operator running optical counters for host retailers such as Meijer, Boscov's, and military exchanges.[21]
• Vision Source — an alliance/buying group of independent optometrists that, measured as a network, tops the optical-sales rankings at roughly $3.2 billion — but it is a membership of independents, not one company.[8]
• Zenni Optical — privately held online value leader. 1-800 Contacts — the largest online contact-lens seller, owned by private-equity firm KKR since 2020.[22] Amazon captures a large share of online eyewear spending (readers, contacts, sunglasses).[23]

5. How the money works

Optical retailers run on two engines: product (frames, prescription lenses, contact lenses, sunglasses) and services (eye exams and fittings, usually delivered by an optometrist who is employed, affiliated, or located next door). In the store category itself, product is the revenue; exam fees often flow through the associated doctor's practice. Layered on top are memberships, subscriptions, and managed-care contracts.

High markups, heavy overhead. Frames and lenses carry famously high retail markups relative to production cost — a structural feature critics tie to the vertical dominance of EssilorLuxottica, which makes lenses and frames, owns designer brands, runs stores, and runs a vision-insurance plan.[24] Gross margins on eyewear are rich, but rent, licensed labor (opticians and optometrists), marketing, and lab costs consume much of it, so operating margins end up as ordinary retail margins. Contact lenses create recurring demand but generally carry lower margins than glasses.[14] Centralized labs and purchasing improve unit economics at scale.[11]

What owners and investors watch:

• Comparable-store ("same-store") sales growth, ideally split into traffic, price, and product mix — the cleanest read on health. National Vision, for example, strung together eleven straight quarters of positive comps through 2025 as its turnaround took hold.[25]
• Average ticket / revenue per customer, driven heavily by the attach rate of higher-margin add-ons: anti-reflective coatings, progressive (multifocal) lenses, blue-light filters, and second pairs.
• Exam capacity and exam-to-purchase conversion — chains grow by adding units, and a key constraint is access to licensed optometrists to staff exam lanes.
• Managed-care / self-pay mix. Warby Parker cites an industry estimate that insurance is used in roughly 60% of U.S. vision-care purchases; plan allowances shape both traffic and average spend.[14]
• Recurring revenue — contact lenses reorder on a schedule and annual exams bring customers back, giving the model a subscription-like backbone.
• For DTC brands — active customers, retention, customer-acquisition cost, and revenue per customer.
• New-store economics. As a company-specific benchmark (not an industry average), National Vision's FY2025 report described a new-store cash investment target of roughly $0.4–$0.6 million and a three-to-five-year invested-capital payback.[11]

Three business models coexist: the value model (National Vision's America's Best is built around offers like two pairs plus an eye exam for roughly $80), the premium model (LensCrafters and designer frames), and the DTC model (Warby's roughly $95–$145 glasses sold online and in sleek stores). Each targets a different point on the price-versus-service curve.

6. What drives demand

• Aging population — the dominant tailwind. Almost everyone develops presbyopia (age-related loss of near focus), which the National Eye Institute notes typically becomes noticeable in the mid-40s and creates a lasting need for correction.[26] The baby-boomer retirement wave keeps expanding this market.
• High, sticky penetration. The Vision Council reports that about 94% of U.S. adults use some form of eyewear (including sunglasses and readers), and the Centers for Disease Control and Prevention (CDC) estimates about 45 million Americans wear contact lenses.[7][27] The large majority of adults need some vision correction, and that share rises steeply with age.
• Rising myopia (nearsightedness). By common public-health estimates myopia affects on the order of a third of Americans and is trending up, linked to screen time and near work — including in children, pulling demand to younger ages.
• Fashion and replacement cycles. Frames are an accessory: consumers buy multiple pairs and replace for style, not only prescription changes. Sunglasses add a fashion-driven, insurance-optional layer.
• Insurance coverage. Vision plans lower out-of-pocket cost, pull demand forward, and lift average spend.[14]
• Discretionary sensitivity. Glasses are a deferrable big-ticket buy, so in downturns consumers trade down to value chains or stretch replacement cycles — though exams and contact-lens refills behave more like staples.
• New category: smart glasses. Ray-Ban Meta and forthcoming Google/Warby devices are turning eyewear into a consumer-electronics frontier, potentially adding a technology-upgrade cycle on top of the vision-correction one.

The physical store remains central: the Vision Council reports that more than 80% of frames and lenses were bought in physical locations in 2025.[7] Telehealth, virtual try-on, same-day labs, and smart eyewear should expand access rather than eliminate the store, rewarding operators with strong clinical controls and trusted brands.

7. Regulation

Optical retail combines ordinary retail rules with health-care and medical-device requirements, plus state licensing.

• FTC Eyeglass Rule (16 CFR Part 456). The Federal Trade Commission (FTC) requires the prescriber to give patients their eyeglass prescription for free at the end of an exam, whether or not they ask — so shoppers can fill it anywhere.[28]
• FTC Contact Lens Rule (16 CFR Part 315), implementing the Fairness to Contact Lens Consumers Act of 2003. It mandates automatic release of the contact-lens prescription, bars tying the prescription to buying lenses from the prescriber, and sets a verification process letting third-party sellers fill prescriptions. Violations can draw civil penalties (up to roughly $53,088 per violation, as adjusted).[28] These pro-competition rules are precisely what let online sellers like 1-800 Contacts, Zenni, and Warby compete with the doctor who wrote the script.
• FDA. The Food and Drug Administration treats contact lenses as medical devices requiring a valid prescription; federal rules also require impact-resistant spectacle lenses.[29]
• State licensing and corporate-practice laws. Optometrists and opticians are state-licensed. Many states restrict corporate ownership, fee-sharing, or lay ownership of optometry practices — Florida, for example, limits lay corporations from practicing optometry through employed practitioners.[30] This is why chains typically use an MSO structure with affiliated independent doctors rather than owning the exam itself. Some states also restrict remote/online refraction (telehealth eye exams).
• Privacy. The Health Insurance Portability and Accountability Act (HIPAA) applies to covered health-care providers and their business associates handling protected health information — but not automatically to every ordinary optical retailer.[31]
• Trade policy. Tariffs on imported frames are an active issue — see Risks.

These rules frequently produce a separation between the retail company and a physician-owned professional entity, linked through an MSO.

8. Competitive dynamics and consolidation

Vertical integration by two giants. EssilorLuxottica sits across the whole chain — lens manufacturing (Essilor), frames and brands (Ray-Ban, Oakley, plus licensed designer names), wholesale, retail (LensCrafters, Sunglass Hut, Pearle Vision, Target Optical), and vision insurance (EyeMed).[10][24] VSP Vision mirrors this on the payer side: the largest vision insurer, it also owns retail (Visionworks and Eyemart Express) and a lens/frame business.[17] The same companies can thus influence both what a consumer's insurance covers and where they buy.

Insurance as a chokepoint. Two networks — VSP and EyeMed — dominate vision benefits and together touch a large majority of insured lives (VSP alone reports tens of millions).[32] Because in-network steering shapes where members shop, controlling the benefit network is a powerful competitive lever.

Concentrated at the firm level, fragmented locally. The 2022 Economic Census shows the four largest firms at 61.5% of receipts and the top 50 at 80.5%.[2] Yet the market stays locally fragmented because independent practices, franchises, licensed departments, and professional entities sit alongside or outside the retail code. Consolidation is ongoing through both strategic and private-equity deals: Goldman's MyEyeDr, Partners Group's EyeCare Partners, VSP's Eyemart Express, and earlier KKR's purchase of 1-800 Contacts.[17][18][19][22] Buying groups like Vision Source aggregate independents' purchasing power as a counterweight.[8]

DTC disruption and the incumbent response. Warby Parker, Zenni, and peers pressured prices and forced incumbents to add e-commerce, virtual try-on, and prescription-renewal tools; virtual try-on is now mainstream and lifts online conversion.[23] Card-spend panels show share fragmenting — online value players and Warby gaining, legacy premium chains slipping.[8] Durable advantages come from insurance-network participation, local convenience and clinical trust, assortment, fast lab turnaround, centralized purchasing, digital marketing, and — critically — the ability to recruit and retain optometrists.

9. Risks

• Consumer / macro sensitivity. Glasses are a deferrable big-ticket buy; weak spending hits the premium end and lens-upgrade attach rates first, even as exams and contact refills hold up.
• Payer pressure and concentration. With two networks dominating vision benefits, reimbursement and network terms are a standing margin risk; plans bring volume but compress pricing.
• Optometrist / clinical labor. A shortage of licensed doctors constrains exam-lane capacity and slows store growth; National Vision has repeatedly flagged doctor recruitment as a limiter.
• Tariffs and supply chain. Most frames are made in China. 2025 tariff increases pushed combined duties on many Chinese optical goods well over 100% (some cited as high as ~178%), pressure that ultimately reaches shelf prices.[33]
• Price and online competition. DTC and marketplace sellers keep compressing margins on commodity frames and contacts.
• Regulatory change. The economics depend on the FTC prescription-release rules staying pro-competition; shifts in scope-of-practice, corporate-practice, or telehealth-refraction rules could move the balance among doctors, chains, and online sellers.
• Vertical-integration and antitrust scrutiny. The integrated giants attract regulatory attention (EssilorLuxottica's structure; the earlier FTC case against 1-800 Contacts over search-ad agreements).
• Roll-up / financial risk. Private-equity consolidation can amplify returns but also magnify integration problems, lease obligations, and debt-service pressure.
• Long-run substitution. Refractive surgery (LASIK/SMILE — laser procedures that reshape the cornea), myopia-control treatments, and presbyopia eye drops could slowly reduce lifelong dependence on eyewear. Smart glasses cut both ways: an opportunity if incumbents own the frame, a threat if Big Tech captures the value.
• Measurement risk. Federal statistics omit or misclassify much optical activity, making market-size comparisons unreliable. The Vision Council's 2025 read illustrates a subtler risk: industry value rose while product volume and exams declined, implying price and mix — not more customer activity — carried revenue.[7]

10. How to invest, and the outlook

Public routes. Three listed names give distinct exposures:

• EssilorLuxottica (EL / ESLOY) — the diversified blue-chip: manufacturing, brands, global retail, insurance, and the fastest-growing smart-glasses franchise (Ray-Ban Meta revenue more than tripled year-on-year).[9][10] The lower-volatility way to own the whole value chain, though it is a foreign-listed conglomerate, not a pure U.S. retailer.
• National Vision (EYE) — the clearest pure-play U.S. optical retailer, a value-chain turnaround delivering multiple quarters of positive same-store sales after winding down its legacy Walmart Vision Center partnership in 2024.[12][25]
• Warby Parker (WRBY) — the DTC growth story with smart-glasses optionality (a Google partnership committing up to $150 million) and a Target shop-in-shop rollout.[13][34]

Contact-lens makers (Alcon, Cooper, Bausch + Lomb) offer adjacent supplier-side exposure. Walmart and Costco are not meaningful eyewear investments despite their optical volume, and their filings do not permit a clean optical valuation. For any of these, compare valuation multiples, free-cash-flow yield, earnings growth, dividend policy, and share price only after adjusting for the mix of pure retail, managed vision care, manufacturing, and professional services.

Private routes — where much of the industry actually changes hands: buying or franchising a store (Pearle Vision franchises; Vision Source membership for independent optometrists), buying an existing independent shop (most qualify as small businesses under the $29.5 million SBA ceiling and are financeable with SBA-backed loans),[5] backing a retail or practice-management platform, financing labs/technology/retail real estate, or co-investing with the private-equity firms and insurers rolling up practices. Due diligence should center on comparable-store sales, traffic, average ticket, insurer mix, exam conversion, contact-lens retention, labor availability, inventory turns, lab performance, new-store payback, acquisition integration, lease liabilities, and compliance with state corporate-practice rules — and, for private deals, normalize owner compensation and separate clinical from retail earnings.

Outlook (forward-looking). The demographic base is durable and slow-moving in the industry's favor: an aging population, rising myopia, and heavy screen use all point to steady long-run demand for correction, and the physical store is not going away. Within that, value and DTC formats look positioned to keep taking share from full-price premium chains, and consolidation of independents should continue. The near-term swing factors are tariffs feeding into retail prices, the availability of optometrists to staff growth, consumer discretionary strength, and — the genuine wild card — the smart-glasses land grab. The central opportunity is less "sell more glasses" than "build a repeatable vision-care relationship." If eyewear re-rates in investors' minds from a staid retail category into a technology-adjacent wearables platform, the companies that control the frame on your face may be valued very differently than their optical-retail history suggests. That is a judgment about the future, not a settled fact.

---

Sources

1. U.S. Census Bureau, County Business Patterns, NAICS 456130 (Optical Goods Retailers), 2023 (establishments, employment, annual and Q1 payroll). https://data.census.gov/table/CBP2023.CB2300CBP
2. U.S. Census Bureau, 2022 Economic Census — Concentration of Largest Firms, NAICS 456130 (firms, receipts, CR4/CR8/CR20/CR50; HHI suppressed). https://api.census.gov/data/2022/ecnsize/groups/EC2200SIZECONCEN.html
3. U.S. Census Bureau, 2022 NAICS: 456130 Optical Goods Retailers (definition and cross-references to 621320 and 339115). https://www.census.gov/naics/?details=456130&input=456130&year=2022
4. U.S. Census Bureau, "NAICS Changes Will Begin to Be Reflected in Economic Surveys and Programs," 2024. https://www.census.gov/library/stories/2024/11/naics-changes.html
5. U.S. Small Business Administration, Table of Size Standards (NAICS 456130), 2023. https://www.sba.gov/document/support-table-size-standards
6. U.S. Census Bureau, County Business Patterns Methodology (coverage limits; nonemployer/small-multiunit undercount). https://www.census.gov/programs-surveys/cbp/technical-documentation/methodology.html
7. The Vision Council, Market inSights 2025 ($69.5B U.S. optical industry; ~94% of adults use eyewear; >80% of frames/lenses bought in physical stores; value up while volume/exams down), 2026. https://thevisioncouncil.org/research
8. Vision Monday, 2025 Top 50 U.S. Optical Retailers (retailer rankings; Vision Source network sales; Walmart optical estimate) and Statista, "Sales of leading U.S. optical retailers," 2025. https://www.visionmonday.com/vm-reports/top-50-retailers/
9. CNBC, "Ray-Ban Meta smart glasses revenue tripled over the year, EssilorLuxottica says," 2025. https://www.cnbc.com/2025/07/28/ray-ban-meta-revenue-tripled-essilorluxottica.html
10. EssilorLuxottica, Half-Year 2024 Results and Universal Registration Document 2024/2025 (revenue; brands and retail banners; EyeMed). https://www.essilorluxottica.com/en/investors/
11. National Vision Holdings, Inc., Form 10-K, Fiscal Year 2025 (store count; new-store investment and payback targets; centralized labs) (SEC EDGAR). https://www.sec.gov/Archives/edgar/data/1710155/000162828026014379/eye-20260103.htm
12. National Vision Holdings, Inc., "Fourth Quarter and Fiscal 2024 Financial Results" (net revenue $1.82B; Walmart Vision Center wind-down); market capitalization via StockAnalysis, 2026. https://nationalvision.gcs-web.com/news-releases/
13. Warby Parker Inc., Form 10-K, Fiscal Year 2025 (store count; stores offering exams; contacts lower margin; ~60% insurance-use estimate) (SEC EDGAR). https://www.sec.gov/Archives/edgar/data/1504776/000150477626000006/wrby-20251231.htm
14. Warby Parker Inc., "Fourth Quarter and Full Year 2024 Results" (revenue $771M, +15%; 2.5M+ active customers), Business Wire, Feb. 27, 2025. https://www.businesswire.com/news/home/20250227280593/en/
15. Walmart Inc., Form 10-K (optical embedded in Health & Wellness; no standalone disclosure). https://stock.walmart.com/financials/
16. Costco Wholesale Corporation, Form 10-K, Fiscal 2025 (optical within warehouse ancillary operations; no separate reporting). https://www.sec.gov/Archives/edgar/data/909832/000090983225000101/cost-20250831.htm
17. VSP Vision, "VSP Global Completes Visionworks Acquisition," 2019, and "VSP Vision Enters Into / Completes Eyemart Express Acquisition," 2024–2025. https://www.prnewswire.com/news-releases/vsp-vision-enters-into-definitive-agreement-to-acquire-eyemart-express-302270786.html
18. MyEyeDr. (Capital Vision Services), "Practice Acquisition and Partnership Overview" (900+ practices; Goldman Sachs–backed). https://acquisitions.myeyedr.com/about
19. Partners Group, "Investment in EyeCare Partners," 2019. https://www.partnersgroup.com/en/news-views/2019/eyecare-partners/
20. Now Optics / Stanton Optical, "Who We Are" (300+ locations; founder-owned). https://www.nowoptics.com/who-we-are
21. U.S. Vision / Refac Optical Group, "About U.S. Vision" (licensed-department operator; host retailers). https://www.usvision.com/
22. Reuters, "KKR to buy online contact lens retailer 1-800 Contacts," 2020. https://www.reuters.com/article/kkr-1-800-contacts-idUSKBN27S1J8
23. Modern Retail, "As online eyewear goes mainstream, fully virtual eye exams remain elusive," 2024. https://www.modernretail.co/technology/as-online-eyewear-goes-mainstream-fully-virtual-eye-exams-remain-elusive/
24. Worse on Purpose, "Why Glasses Cost $800: The EssilorLuxottica Eyewear Monopoly," 2024 (markup and vertical-integration critique). https://www.worseonpurpose.com/p/your-glasses-got-worse-on-purpose
25. National Vision Holdings, Inc., "Third Quarter 2025 Financial Results" (positive comparable-store-sales streak), Form 8-K, 2025. https://www.sec.gov/Archives/edgar/data/1710155/000162828025049201/ex991-q32025earningsrelease.htm
26. U.S. National Eye Institute, "Presbyopia," 2024. https://www.nei.nih.gov/eye-health-information/eye-conditions-and-diseases/presbyopia
27. U.S. Centers for Disease Control and Prevention, "About Contact Lenses" (~45 million U.S. wearers), 2025. https://www.cdc.gov/contact-lenses/about/index.html
28. U.S. Federal Trade Commission, "The Eyeglass Rule (16 CFR Part 456)" and "The Contact Lens Rule (16 CFR Part 315): A Guide for Prescribers and Sellers." https://www.ftc.gov/business-guidance/resources/contact-lens-rule-guide-prescribers-sellers
29. U.S. Food and Drug Administration, "Contact Lenses" (regulated medical devices; valid prescription required). https://www.fda.gov/medical-devices/consumer-products/contact-lenses
30. Florida Senate, Florida Statutes §463.014 (restrictions on lay-corporation practice of optometry), 2024. https://www.flsenate.gov/Laws/Statutes/2024/463.014
31. U.S. Department of Health and Human Services, "Covered Entities and Business Associates" (HIPAA applicability). https://www.hhs.gov/hipaa/for-professionals/covered-entities/index.html
32. Mark Farrah Associates, "Highly-Concentrated Vision Insurance Market Increasing" (VSP/EyeMed covered lives), 2024. https://www.markfarrah.com/mfa-briefs/highly-concentrated-vision-insurance-market-increasing/
33. Healio, "Optical products from China now tariffed as high as 178%," 2025, and The Vision Council, "Updates on Tariffs Impacting the Optical Industry," 2025. https://www.healio.com/news/optometry/20250423/optical-products-from-china-now-tariffed-as-high-as-178
34. Business Wire, "Warby Parker Partners with Google To Develop Intelligent Eyewear," May 20, 2025. https://www.businesswire.com/news/home/20250520232084/en/